Kidney transplantation
Conditions
Interventions
Tacrolimus + basiliximab + steroid + mizoribine
Tacrolimus + basiliximab + steroid + cellcept
Sponsors
AMCT
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Living donor kidney transplantation. 2.Primary kidney transplantation. 3.ABO blood type compatible (including semi-compatible). 4.Gender free, any case of uremia. The patient or whose family has submitted (if the patient is showing disturbance of consciousness or decreased ability to understand) written consent forms based on their free choice once adequate information and understandings are obtained regarding the study upon the participation.
Exclusion criteria
Exclusion criteria: 1.The patient who is pregnant or a female patient who is expecting to become pregnant. 2.The patient who has anti-donor antibody (anti-T antibody). 3.The patient who has severe infections. 5.The patient with whom the physician-in-charge considered inappropriate as a subject of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rejection (incidence, types, severity) | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient survival, graft survival, incidence of adverse effects / abnormalities in the laboratory values. | — |
Countries
Japan
Outcome results
None listed